# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-028188
Filing Date
2022-08-04
Accepted
2022-08-04 16:01:33
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | brhc10040431_defa14a.htm | DEFA14A | 14588
2 |  | graphic01.jpg | GRAPHIC | 338557
3 |  | graphic02.jpg | GRAPHIC | 270676
| Complete submission text file | 0001140361-22-028188.txt |  | 854963

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51173 | Film No.: 221136368
SIC: 2834 Pharmaceutical Preparations